News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Paciente_ensayo
Positive aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
Access to innovation
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial…
Partners - Oryzon Genomics
Oryzon-Asebio-Biotecnologia
ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders
Corporate
All resolutions were approved and 35% of the issued shares represented.
Partners - Oryzon Genomics
Fundación_Medina_Welab_AseBio
WeLab Barcelona and Fundación MEDINA will collaborate to expand the offer of R&D services and capabilities for the discovery and development of new medicines
Innovative drugs
This collaboration allows combining experience and resources for the discovery and development of…
Partners - Fundación Medina
Oficina_Genesis_Biomed_Valencia
GENESIS Biomed opens a new office in Valencia
Corporate
This new location of GENESIS Biomed in the BioHub joins the existing locations in Barcelona and…
Partners - GENESIS Biomed
Thomas_Harth_Ysios
Tagworks Pharmaceuticals Announces $64 Million in Series A Financing to Advance Click-to-Release Therapeutics
Access to innovation
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture…
Partners - Ysios Capital Partners
Biotecnología_AseBio_Laboratorio
Positive preclinical data of ORY-4001 for the treatment of Charcot-Marie-Tooth (CMT) disease presented at the 2023 Peripheral Nerve Society (PNS) Annual Meeting
Healthcare
Comprehensively reversed disease progression symptoms in a CMT mice model.
Partners - Oryzon Genomics
Laboratorio_Biotecnología_AseBio
‘JAMA Neurology’ publishes the results from Phase 1b/2a clinical trial of the neuroprotective drug ApTOLL for ischemic stroke
Healthcare
The results from APRIL study, previously presented at the International Stroke Conference 2023,…
Partners - AptaTargets
log
ZIP Solutions and YIMA Announce Strategic Co-Marketing Agreement for Gene Therapy
Healthcare · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine · Advanced therapies · International
ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI…
Partners - Biotechnology Assets
Biolan-AseBio-Biotecnologia
BIOLAN succesfully advances in the development of the european project Aquavitae
Agriculture · Corporate
BIOLAN is currently part of the AQUAVITAE project, funded by the European Commission and which main…
Partners - Biolan